CN1242812C - 重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶剂及其生产方法 - Google Patents
重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶剂及其生产方法 Download PDFInfo
- Publication number
- CN1242812C CN1242812C CN 03110927 CN03110927A CN1242812C CN 1242812 C CN1242812 C CN 1242812C CN 03110927 CN03110927 CN 03110927 CN 03110927 A CN03110927 A CN 03110927A CN 1242812 C CN1242812 C CN 1242812C
- Authority
- CN
- China
- Prior art keywords
- gel
- csf
- rhgm
- macrophage colony
- colony stimulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims description 18
- 210000002540 macrophage Anatomy 0.000 title abstract description 9
- 239000003349 gelling agent Substances 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
- 210000003714 granulocyte Anatomy 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 15
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 239000000758 substrate Substances 0.000 claims description 27
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 12
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 9
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 9
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 9
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 9
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 9
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 7
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 7
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 7
- 239000004520 water soluble gel Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 230000035876 healing Effects 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 239000003381 stabilizer Substances 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 239000002562 thickening agent Substances 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 102000007644 Colony-Stimulating Factors Human genes 0.000 abstract 2
- 108010071942 Colony-Stimulating Factors Proteins 0.000 abstract 2
- 229940047120 colony stimulating factors Drugs 0.000 abstract 2
- 206010053615 Thermal burn Diseases 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 19
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002607 hemopoietic effect Effects 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229920000136 polysorbate Polymers 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000003448 neutrophilic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- -1 antiseptic Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 210000003725 endotheliocyte Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 101800000263 Acidic protein Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000006052 T cell proliferation Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000007068 beta-elimination reaction Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000005482 chemotactic factor Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
时间(月)样品 | 0 | 2 | 4 | 6 | 8 | 10 | 12 |
第一批 | 1.8×107 | 1.8×107 | 1.8×107 | 1.7×107 | 1.7×107 | 1.6×107 | 1.5×107 |
第二批 | 1.6×107 | 1.5×107 | 1.6×107 | 1.5×107 | 1.5×107 | 1.5×107 | 1.4×107 |
第三批 | 1.5×107 | 1.5×107 | 1.5×107 | 1.3×107 | 1.3×107 | 1.2×107 | 1.2×107 |
时间(月)样品 | 0 | 2 | 4 | 6 | 8 | 10 | 12 |
第一批 | 1.7×107 | 1.7×107 | 1.5×107 | 1.2×107 | 0.9×107 | 0.9×107 | |
第二批 | 1.8×107 | 1.8×107 | 1.6×107 | 1.1×107 | 0.8×107 | 0.8×107 | |
第三批 | 1.6×107 | 1.6×107 | 1.5×107 | 1.2×107 | 0.8×107 | 0.8×107 |
时间(月)样品 | 0 | 1 | 2 | 3 | 4 | 5 | 6 |
第一批 | 1.8×107 | 1.5×107 | 1.4×107 | 1.2×107 | 0.9×107 | ||
第二批 | 1.2×107 | 1.2×107 | 1.3×107 | 1.2×107 | 0.8×107 | ||
第三批 | 1.5×107 | 1.4×107 | 1.5×107 | 1.3×107 | 0.8×107 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03110927 CN1242812C (zh) | 2003-01-21 | 2003-01-21 | 重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶剂及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03110927 CN1242812C (zh) | 2003-01-21 | 2003-01-21 | 重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶剂及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1519022A CN1519022A (zh) | 2004-08-11 |
CN1242812C true CN1242812C (zh) | 2006-02-22 |
Family
ID=34283310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03110927 Expired - Lifetime CN1242812C (zh) | 2003-01-21 | 2003-01-21 | 重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶剂及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1242812C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1939534B (zh) * | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
-
2003
- 2003-01-21 CN CN 03110927 patent/CN1242812C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1519022A (zh) | 2004-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6645948B2 (en) | Nutritional composition for the treatment of connective tissue | |
EP2489338B1 (en) | Dry wound dressing and drug delivery system | |
EP3154596A1 (en) | Anti-cancer effects of proteasome inhibitors in combination with glucocorticoids, arsenic containing compounds, and ascorbic acid | |
US20080226724A1 (en) | Prevention of hydrogel viscosity loss | |
MX2007014856A (es) | Composicion de factor de crecimiento epidermico, un proceso para el mismo y su aplicacion. | |
JPH11504899A (ja) | 獣医学および医学用途用化合物 | |
CN112107592A (zh) | 一种具有修复作用的口腔溃疡贴膜及其制备方法 | |
WO2018226479A1 (en) | Compositions and methods for treating wounds | |
RU2636530C2 (ru) | Фармацевтическая композиция для лечения ран и ожогов | |
KR20130070307A (ko) | 국소 투여용 지속형 치주염 치료제 조성물 | |
US10022394B2 (en) | Antiinfective composition | |
CN1242812C (zh) | 重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶剂及其生产方法 | |
CN115590787B (zh) | 一种用于祛痘和皮肤修复的组合物及其制备方法与应用 | |
CN111991417A (zh) | 一种具有生理响应性的次氯酸凝胶及其在皮肤创面中的应用 | |
CN1238054C (zh) | 一种用于抑杀幽门螺杆菌的生物制剂及其制备方法和应用 | |
JPS6011026B2 (ja) | 新規アミノ酸誘導体の製法 | |
US20230082131A1 (en) | Compositions including amelogenin and uses thereof | |
US20240108697A1 (en) | Antimicrobial compositions | |
CN112773816B (zh) | 一种创面修复喷剂及其制备方法和应用 | |
RU2349339C1 (ru) | Средство, обладающее иммуномодулирующим, антивирусным, антибактериальным, антиоксидантным, мембраностабилизирующим, стимулирующим регенерацию хрящевой и соединительной ткани свойствами | |
RU2691144C1 (ru) | Комбинированная композиция для лечения инфицированных ран различного генеза | |
RU2209074C2 (ru) | Состав для лечения ожогов | |
EP0238207B1 (en) | Bactericidal mixtures | |
US20200023042A1 (en) | Composition for wound healing | |
JP4461727B2 (ja) | 外用剤組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG WIN SPORTS PRODUCTS CO., LTD. Free format text: FORMER OWNER: JIANG XINMIN Effective date: 20101102 |
|
C56 | Change in the name or address of the patentee | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 324109 ZHEJIANG WIN SPORTS PRODUCTS CO., LTD., DONGSHANTOU VILLAGE, HECUN TOWN, JIANGSHAN CITY, ZHEJIANG PROVINCE TO: 324109 JIANGSHAN WIN SPORTS PRODUCTS CO., LTD., AOPING TOWNSHIP, HECUN TOWN, JIANGSHAN CITY, ZHEJIANG PROVINCE |
|
CP01 | Change in the name or title of a patent holder |
Address after: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee after: CHANGCHUN GENESCIENCE PHARMACEUTICALS Corp. Address before: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee before: CHANGCHUN GENESCIENCE PHARMACEUTICAL Co.,Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: JINSAI MEDICINE CO., LTD., CHANGCHUN Free format text: FORMER NAME: CHANGCHUN GENSCI PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee after: CHANGCHUN GENESCIENCE PHARMACEUTICAL Co.,Ltd. Address before: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee before: CHANGCHUN GENESCIENCE PHARMACEUTICALS Corp. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee after: CHANGCHUN GENESCIENCE PHARMACEUTICALS Corp. Address before: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee before: CHANGCHUN GENESCIENCE PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee after: CHANGCHUN GENESCIENCE PHARMACEUTICAL Co.,Ltd. Address before: 130012 No. 72 Tianhe street, hi tech Industrial Development Zone, Jilin, Changchun Patentee before: CHANGCHUN GENESCIENCE PHARMACEUTICALS Corp. |
|
CP01 | Change in the name or title of a patent holder | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060222 |